1. Home
  2. RCEL vs MMLP Comparison

RCEL vs MMLP Comparison

Compare RCEL & MMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • MMLP
  • Stock Information
  • Founded
  • RCEL N/A
  • MMLP 2002
  • Country
  • RCEL United States
  • MMLP United States
  • Employees
  • RCEL N/A
  • MMLP N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • MMLP Oil Refining/Marketing
  • Sector
  • RCEL Health Care
  • MMLP Energy
  • Exchange
  • RCEL Nasdaq
  • MMLP Nasdaq
  • Market Cap
  • RCEL 140.5M
  • MMLP 134.9M
  • IPO Year
  • RCEL N/A
  • MMLP 2002
  • Fundamental
  • Price
  • RCEL $5.54
  • MMLP $3.14
  • Analyst Decision
  • RCEL Strong Buy
  • MMLP
  • Analyst Count
  • RCEL 4
  • MMLP 0
  • Target Price
  • RCEL $13.75
  • MMLP N/A
  • AVG Volume (30 Days)
  • RCEL 1.3M
  • MMLP 8.5K
  • Earning Date
  • RCEL 11-06-2025
  • MMLP 10-20-2025
  • Dividend Yield
  • RCEL N/A
  • MMLP 0.65%
  • EPS Growth
  • RCEL N/A
  • MMLP N/A
  • EPS
  • RCEL N/A
  • MMLP N/A
  • Revenue
  • RCEL $74,884,000.00
  • MMLP $715,480,000.00
  • Revenue This Year
  • RCEL $22.92
  • MMLP $4.19
  • Revenue Next Year
  • RCEL $37.07
  • MMLP N/A
  • P/E Ratio
  • RCEL N/A
  • MMLP N/A
  • Revenue Growth
  • RCEL 38.32
  • MMLP N/A
  • 52 Week Low
  • RCEL $3.60
  • MMLP $2.56
  • 52 Week High
  • RCEL $14.16
  • MMLP $4.02
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 54.84
  • MMLP 48.79
  • Support Level
  • RCEL $5.03
  • MMLP $3.02
  • Resistance Level
  • RCEL $5.61
  • MMLP $3.31
  • Average True Range (ATR)
  • RCEL 0.39
  • MMLP 0.14
  • MACD
  • RCEL 0.00
  • MMLP 0.01
  • Stochastic Oscillator
  • RCEL 34.69
  • MMLP 53.95

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About MMLP Martin Midstream Partners L.P. Limited Partnership

Martin Midstream Partners LP has a diverse set of operations focused in the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing and distribution; and natural gas liquids marketing, distribution and transportation services. Company operates in four segment Terminalling and storage, Transportation, Sulfur service and Specialty products segment. Majority of the revenue derived from Specialty products segment.

Share on Social Networks: